Stereotactic Ablative Radiation Therapy for Metastatic Renal Cell Carcinoma – A Review of Evidence
Because of its remarkable precision in providing targeted radiation, recent evidence supports Stereotactic Ablative Radiation Therapy (SABR) as a promising non-invasive treatment approach for metastatic renal cell carcinoma, minimizing harm to adjacent healthy tissues. With regards to its heterogen...
Saved in:
| Main Authors: | Hima Bora, Gautam Sarma, Partha Pratim Medhi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Vilnius University Press
2025-04-01
|
| Series: | Acta Medica Lituanica |
| Subjects: | |
| Online Access: | https://www.journals.vu.lt/AML/article/view/38595 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Case Report: Papillary renal cell carcinoma complicated by ipsilateral renal tuberculosis
by: Zhong Tian, et al.
Published: (2025-08-01) -
Nivolumab plus cabozantinib in metastatic renal cell carcinoma: real-world evidence from the international ARON-1 study
by: Maria T. Bourlon, et al.
Published: (2025-07-01) -
Managing metastatic renal cell carcinoma-challenges, pitfalls, and outcomes in the real world
by: Karnam Ashok Kumar, et al.
Published: (2016-01-01) -
An experience of radiofrequency ablation in the treatment of renal cell carcinoma
by: P. V. Glybochko, et al.
Published: (2014-06-01) -
Effectiveness and Safety of Systemic Therapy and Stereotactic Body Radiotherapy in Oligoprogressive and Oligometastatic Hepatocellular Carcinoma
by: Song Z, et al.
Published: (2025-05-01)